Status:
COMPLETED
Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
Lead Sponsor:
Chulalongkorn University
Conditions:
Premenstrual Syndrome
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether low-dose combine oral contraceptives (COC) containing desogestrel 150 mg and drospirenone 3 mg are effective in the treatment of Premenstrual symptoms...
Detailed Description
Premenstrual syndrome is commonly reported 20-90 percent in reproductive-aged women. Only a small percentage of women (2 to 5%) have significant premenstrual symptoms defined as Premenstrual dysphoric...
Eligibility Criteria
Inclusion
- age 18-35years
- Regular menses, I:21-35 days
- Willingness to take COC for 6 months
- No history of COC in last 6 months
- No history of injected contraception in last 6 months
- History of implant contraception need to have regular menses 3 cycles
- History of miscarriage need to have regular menses 3 cycles
Exclusion
- Pregnant or suspected pregnant
- Breast feeding
- Smoking
- Contraindication of WHO 2,3 and 4
- PMDD
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01482338
Start Date
June 1 2011
End Date
March 1 2012
Last Update
March 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Family Unit, King Chulalongkorn Memorial Hospital
Bangkok, Bangkok, Thailand, 10330